Global Acute Ischemic Stroke Diagnosis and Treatment Market – Industry Trends and Forecast to 2030

Global Acute Ischemic Stroke Diagnosis and Treatment Market, By Type (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, Others), Surgery Type (Carotid Endarterectomy, Angioplasty, Endovascular Mechanical Thrombectomy), Treatment (Tissue Plasminogen Activator, Anticoagulant, Antiplatelet, Antihypertensive), Age Group (Adult, Geriatric, Child) – Industry Trends and Forecast to 2030.

Acute Ischemic Stroke Diagnosis And Treatment Market Analysis and Size   

Acute ischemic stroke generally refers to a sudden loss of certain brain functions due to uneven or lack of blood to the brain. Acute ischemic functions are largely produced by atherosclerosis plaques blocking blood vessels, blood clots locking the blood distribution to or from arteries nourishing the brain, or narrowing of blood vessels of the brain. The rapid technological advancement in diagnosis and surgical equipment is among the significant factors expected to fuel the growth and demand of the acute ischemic stroke diagnosis and treatment market. In addition, the increase in the number of patients with stroke and the rise in ischemic stroke cases are also anticipated to push the growth in the global acute ischemic stroke diagnosis and treatment market over the forecast period of 2023 to 2030.

Data Bridge Market Research analyses that the acute ischemic stroke diagnosis and treatment market, which was USD 1479.77 million in 2022, would rocket up to USD 2558.32 by 2030 and is expected to undergo a CAGR of 6.7% during the forecast period. “Magnetic Resonance Imaging (MRI)” dominates the type segment of the acute ischemic stroke diagnosis and treatment market owing to the preciseness in diagnosing ischemic stroke. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Acute Ischemic Stroke Diagnosis And Treatment Market Scope and Segmentation

Market Definition

Acute ischemic stroke is when blood flow to the brain is suddenly blocked, leading to brain cell damage. Diagnosis involves assessing medical history, physical examination, and neuroimaging techniques such as CT or MRI scans. Treatment aims to restore blood flow and prevent further damage. Options include administering clot-dissolving drugs or performing a mechanical thrombectomy to remove the clot directly.

Acute Ischemic Stroke Diagnosis And Treatment Market Dynamics

Drivers

• Increasing Prevalence of Stroke

The rising prevalence of stroke cases worldwide is a major driver of the acute ischemic stroke market. Factors such as an aging population, sedentary lifestyles, high blood pressure, diabetes, and obesity increase the incidence of stroke, leading to a higher demand for diagnosis and treatment options.

• Technological Advancements in Diagnostics and Imaging

Advances in diagnostic techniques and neuroimaging technologies have greatly improved the ability to detect and diagnose acute ischemic stroke. Innovations in CT scans, MRI scans, and other imaging modalities enable quicker and more accurate identification of ischemic stroke, leading to timely intervention and treatment.

Opportunities

• Increasing awareness regarding the stroke

The increase in awareness regarding the stroke and its available treatment options in the market, favorable government initiatives and rapid rise in technological advancements in surgical procedures are expected to offer significant growth opportunities for the acute ischemic stroke diagnosis and treatment market in the forecast period of 2023-2030.

Restraints/Challenges

• High cost of treatment

The high cost of treatment and unfavorable reimbursement scenario are estimated to limit the growth of the acute ischemic stroke diagnosis and treatment market, whereas the various complexities related to product development and manufacturing can challenge the growth of the acute ischemic stroke diagnosis and treatment market in the forecast period of 2023-2030

This acute ischemic stroke diagnosis and treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Ischemic  stroke diagnosis and treatment Market contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In April 2023, Genentech announced partnership with University of Washington, Institute for Health Metrics and Evaluation (IHME), PicnicHealth and Cleveland Clinic to focus on improving brain health outcomes. This collaboration majorly focuses on assessing the complexity, and economic impact on patients during neurological care

• In October 2022, Royal Philips announced that it will showcase its latest advances to support the treatment of stroke patients. Also, the company is working in association with stroke care partners such as MedTech stroke care company Nicolab to enable quick and effective response for stroke patients.

Global Acute Ischemic Stroke Diagnosis and Treatment Market Scope

The acute ischemic stroke diagnosis and treatment market is segmented based on type, surgery type, treatment, and age group. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Type

• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Carotid Ultrasound
• Cerebral Angiography
• Electrocardiography
• Echocardiography
• Others

Surgery Type

• Carotid Endarterectomy
• Angioplasty
• Endovascular Mechanical Thrombectomy

Treatment

• Tissue Plasminogen Activator
• Anticoagulant
• Antiplatelet
• Antihypertensive

Age Group

• Adult
• Geriatric
• Child

Acute Ischemic Stroke Diagnosis and Treatment Market Regional Analysis/Insights

The acute ischemic stroke diagnosis and treatment market is analysed and market size insights and trends are provided by country, type surgery type, treatment, age group, as referenced above.

The countries covered in the acute ischemic stroke diagnosis and treatment market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.

North America dominates the market because its well-advanced healthcare system supports strong research and development activities for ischemic stroke diagnosis and treatment research. Many major players in the market have a stronghold in North America, contributing to the distribution of ischemic stroke diagnosis and treatment for all other regions worldwide.

Asia-Pacific is expected to grow the market in the forecast period of 2023-2030 because of the rising population at risk of ischemic stroke.

The country section of the report also provides individual market-impacting factors and domestic regulation changes that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The acute schemic stroke diagnosis and treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for acute ischemic stroke diagnosis and treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the acute ischemic stroke diagnosis and treatment market. The data is available for historic period 2010-2020.

Competitive Landscape and Acute Ischemic  Stroke Diagnosis And Treatment Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the acute ischemic stroke diagnosis and treatment market are:

• Abbott (U.S.)
• Cardinal Health (U.S)
• Genentech, Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Medtronic (Ireland)
• GENERAL ELECTRIC (U.S.)
• Stryker (U.S.)
• Merck & Co., Inc. (U.S.)
• Siemens Healthcare Private Limited (Germany)
• Hitachi Medical Systems (Japan)
• Boston Scientific Corporation (U.S.)
• Neusoft Corporation (China)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• Teleflex Incorporated (U.S.)
• Bayer AG (Germany)
• B. Braun Melsungen AG (Germany)
• AliveCor, Inc. (U.S.)
• F. Hoffmann-La Roche Ltd (Siwtzerland)
• Sanofi (France)
• Johnson & Johnson Services, Inc. (U.S.)